<DOC>
	<DOCNO>NCT00246844</DOCNO>
	<brief_summary>This study examine whether insulin-producing cell pancreas ( beta cell ) recover patient type 1 diabetes pancreas transplant . In type 1 diabetes , body 's immune system destroy beta cell . Patients treat insulin shot pancreas transplant control blood sugar . Some experiment suggest pancreas may capacity recover insulin-producing capacity , ability negate factor continue immune attack erratic blood sugar level patient . Patients pancreas transplant may unique situation allow pancreas regrow beta cell two reason : 1 ) medicine take prevent rejection transplant pancreas weaken immune system ; 2 ) near-normal blood sugar level function transplant pancreas . This study test hypothesis sample blood patient ' hepatic vein , drain liver native pancreas iliac vein , drain transplant pancreas . This determine whether insulin come transplant pancreas ( iliac vein ) liver native pancreas ( hepatic vein ) . Patients 18 year age older stable pancreatic transplant function 5 year may eligible study . Candidates screen medical history physical examination . Participants admit hospital 2 day full medical examination , blood test procedure determine insulin production . The procedure include placement catheter neck groin blood sampling . Participants closely monitor procedure discharge home complication .</brief_summary>
	<brief_title>Assessment Insulin Production From Native Pancreas Patients With Pancreas Transplants</brief_title>
	<detailed_description>Type 1 diabetes mellitus ( T1DM ) think result autoimmune destruction insulin produce beta-cells find within pancreatic islet Langerhans . In addition autoimmune process however , many study show hyperglycemia also toxic islet . Interventional study show , instance , either tight glycemia control immunosuppression preserve C-peptide production . We hypothesize patient immunosuppressed euglycemic display evidence native pancreas recover beta-cell function . We ask whether pancreas transplant recipient , due immunosuppression require prevent allograft loss , improve glycemia control result transplant pancreas , might display recovery native pancreatic islet function . Our preliminary data suggest patient without C-peptide production prior receive islet transplant appear recover endogenous pancreatic insulin secretion islet transplantation . We study whole pancreas transplant recipient , specifically grafts function least 5 year . We test native pancreas insulin production infuse arginine peripheral vein , selectively/simultaneously sample blood C-peptide level hepatic vein vein drain pancreatic allograft . Unlike previous study islet transplant recipient , study require portal vein cannulation , study require hepatic iliac vein cannulation , much easy accomplish , associate much less risk patient . Samples obtain site test C-peptide level . In addition , find evidence native pancreas insulin production , look variety clinical variable see correlate recovery function .</detailed_description>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>INCLUSION CRITERIA : Patients include : Age great equal 18 GFR great 50 ml/min/1.73 m2 History consistent T1DM prior pancreas transplant EXCLUSION CRITERIA : Liver dysfunction ( elevate liver enzymes , clinical evidence portal hypertension ) coagulopathy ( elevate INR Partial Thromboplastin Time ) History repeat instrumentation/cannulation jugular femoral vessel Dye allergy Pregnancy Known vascular anomaly Anemia Hgb less 10</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 15, 2007</verification_date>
	<keyword>Transplant</keyword>
	<keyword>Diabetes</keyword>
	<keyword>C-Peptide</keyword>
	<keyword>B Cell</keyword>
	<keyword>Immunosuppression</keyword>
	<keyword>Type 1 Diabetes</keyword>
	<keyword>Pancreas Transplant</keyword>
</DOC>